Susquehanna Fundamental Investments’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,213	Closed	-$73.4K	–	238
2023 Q3	$73.4K	Sell	8,213 -2,039	-20%	-$18.2K	﹤0.01%	349
2023 Q2	$88.5K	Hold	10,252	–	–	﹤0.01%	611
2023 Q1	$108K	Hold	10,252	–	–	﹤0.01%	899
2022 Q4	$348K	Buy	+10,252	New	+$348K	0.01%	955